. 2012 Jul 9;1(7):557–565. doi: 10.5966/sctm.2012-0025

Table 1.

Characteristics of treatment groups (mean ± SE) used in this study

graphic file with name sct00712-0064-t01.jpg

^aCompared with pretreatment weight, post-treatment weight varied significantly (p = 0.04).

^bCompared with streptozotocin-treated groups, the wild-type control group weight was significantly greater (p = 0.0002).

^cCompared with streptozotocin-treated groups, the wild-type control group blood glucose was significantly less (p = 0.0001).

Abbreviations: MSC, conventional mesenchymal stem cell; MSC2, anti-inflammatory mesenchymal stem cells.